Abstract. The incidence of hepatocellular carcinoma (HCC) in Japan has been increasing. The aim of the present study was to analyze epidemiological changes in Japanese HCC patients. A total of 463 patients with HCC diagnosed at our hospital between 1982 and 2001 were recruited for this study. Cohorts of patients with HCC were categorized into intervals of five years. The number of HBV-and HCV-associated HCC cases had decreased and increased in 1987-1991, respectively, and thereafter reached a plateau. The mean age of patients at diagnosis of HCV-associated HCC showed a steady significant increase from 60 to 68 years of age during the period, suggesting that these findings were associated with a shift toward an older-age group that had the highest rate of HCV infection. The mean age of patients with other types of HCC did not significantly change during the period. Since it is known that the prevalence of HCV infection in young Japanese persons is low and that the incidence of HCV infection is very low at present, our findings may indicate that the prevalence of HCC will decline in Japan, an advanced country with regard to HCV-associated HCC, in the near future.
Introduction
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver. HCC accounts for approximately 6% of all human cancers. It is estimated that half a million cases occur worldwide annually, making HCC the fifth most common malignancy in men and the ninth in women (1) (2) (3) (4) (5) (6) . The ageadjusted HCC mortality rate has increased in recent decades in Japan (7) . Similarly, a trend of increasing rates of HCC has been reported from several developed countries in North America, Europe and Asia (8, 9) . HCC often develops in patients with liver cirrhosis caused by hepatitis B virus (HBV), hepatitis C virus (HCV), excessive alcohol consumption or non-alcoholic fatty liver disease. Of the hepatitis viruses that cause HCC, HCV is more common than HBV in Japan (10) (11) (12) (13) .
Although the age-adjusted incidence rates of HCC have increased during the period of rising HCC mortality in Japan, sequential changes in background features of HCC patients are not fully understood (14) . Yoshizawa et al report that deaths due to HCC in Japan have continued to increase in males, particularly in those older than 60 years of age in the past 3 decades, although the reasons for this are unclear (15) . To clarify factors affecting epidemiological changes in Japanese HCC patients, especially the change in age distribution, we analyzed the underlying features of HCC patients in a singlecenter, hospital-based study, including demographic data, etiology and stage of liver disease, and tumor characteristics.
Patients and methods

Patients.
A total of 463 patients with HCC diagnosed between January 1982 and December 2001 in the First Department of Internal Medicine, Nagasaki University School of Medicine, were recruited for this study. The diagnosis of HCC was based on AFP levels and imaging techniques including ultrasonography (USG), computerized tomography (CT), magnetic resonance imaging (MRI), hepatic angiography (HAG), and/or liver biopsy. The diagnostic criteria for HCC were either a confirmative liver biopsy or elevated AFP (≥20 ng/ml) and neovascularization in HAG and/or CT. Cohorts of patients with HCC were categorized into five-year intervals (1982-1986, 1987-1991, 1992-1996 and 1997-2001) .
Of the persons who visited Nagasaki Tarami hospital for health screening during the period from January 1996 to December 2002, 13869 were first-time visitors. There are same region of Nagasaki University School of Medicine and Nagasaki Tarami hospital. All of them received blood screening for the anti-HCV antibody (HCVAb) and the data were 
Results
Clinical features of the studied patients.
A total of 463 patients with HCC were diagnosed at our hospital from 1982 to 2001. There were 362 male (78.2%) and 101 female (21.8%) patients, with a mean age of 63 years. The proportion of patients diagnosed with HBV-associated HCC was 20.1% (93 of 463), whereas 68.0% (315 of 463) had HCV-associated HCC, and an additional 3.7% (17 of 463) had HCC associated with both viruses. Seven of the other 38 patients had a history of significant alcohol intake and the remaining 31 had no known etiology.
As shown in Figs. 1 and 2, the number of HBV-associated HCC cases decreased in 1987 -1991 and thereafter stabilized, whereas HCV-associated HCC increased and reached a plateau in 1987-1991. On the other hand, the mean age at diagnosis of HCV-associated HCC steadily increased, although patients with other types of HCC had no significant change during the observation period. Fig. 3 shows the age distribution of patients with HBV-and HCV-associated HCC during the four 5-year periods. There was no difference in the age distribution of patients with HBV-associated HCC during these periods. In contrast, HCV-associated HCC obviously had an increase in the number of patients aged more than 60 years.
Background features for patients with HBV-and HCVassociated HCC.
To examine the factors affecting the change in age distribution, the mean age of patients with HBV-and HCV-associated HCC was analyzed according to each background in Tables I and II , respectively. The mean age of patients with HBV-associated HCC was not significantly different except for gender. On the other hand, in HCVassociated HCC, patients with excessive alcohol consumption, diabetes mellitus or Child-Pugh stage C in addition to male gender were younger age than those without as described above. Table III shows the mean age and other characteristics at diagnosis of HCV-associated HCC in five-year intervals (1982-1986, 1987-1991, 1992-1996, and 1997-2001 ). In addition to mean age, the number of patients with Child-Pugh stage A showed a significant increase during the studied periods. Alcohol consumers significantly decreased during the periods.
In analysis of patients without alcohol consumption and Child-Pugh stage C in HCV-associated HCC, the mean ages 62, 63, 64 and 68 years of age, respectively (1982-1986 vs. 1997-2001, p=0 .0001) (Table IV) .
Age-specific prevalence of HCV infection in the general population of studied area. The age-specific prevalence of HCVAb among the 13869 persons who visited Nagasaki prefecture Tarami Hospital for health screening from 1996 to 2002 is shown in Table V . Although the positive rate for HCVAb was 1.64% (277 of 13869) as a whole, it was higher in the group aged more than 60 years irrespective of gender.
Discussion
Our study was a single-center, hospital-based study designed to examine the sequential change in backgrounds among patients with HCC during the past 2 decades. More than 90% of our patients had chronic HBV or HCV infections. During the observation period, the number of HBV-and HCV-associated HCC cases decreased and increased in 1987-1991, respectively, and thereafter reached a plateau. These findings were consistent with previous reports from Japan (7, 14) . Additionally, the age- Table I . The background of the 93 patients with HBVassociated HCC. 
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a Mann-Whitney U test. b ANOVA. SD, standard deviation; NS, not significant. Table II . The background of the 315 patients with HBVassociated HCC. 
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a Mann-Whitney U test. b ANOVA. SD, standard deviation; NS, not significant.
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specific prevalence of HCV infection in the general population of the studied area was also in agreement with Japanese epidemiological studies which showed a high prevalence of HCVAb in the population, 60 years of age and older (15) (16) (17) .
In analysis of background features among HCC patients, HBV-associated HCC cases revealed no significant change, whereas the mean age of patients with HCV-associated HCC steadily increased from 60 to 68 years of age during the studied period. In patients with HCV-associated HCC, factors such as male gender, excessive alcohol consumption and diabetes mellitus, which are known to be risk factors for HCC, contributed to lowering the age of HCC occurrence. Furthermore, patients with Child-Pugh stage C were younger than those with stages A and B. When the mean age of HCV patients without alcohol consumption and Child-Pugh stage C, which may contribute to aging of HCV-associated HCC, was ONCOLOGY REPORTS 16: 837-843, 2006 Table III. The mean age and the other characteristics of HCV-associated HCC at diagnosis in 5-year intervals. Period  1982-1986  1987-1991  1992-1996  1997-2001  Total  P- .  56  87  84  88  315 Age (years) (SD) 60 (8) 63 (7) 65 (8) 68 (6) 
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SD, standard deviation; NS, not significant. Table IV . Mean age of HCV-associated HCC without excessive alcohol consumers and Child-Pugh stage C. 
analyzed, a significant increase was also found during the studied period. Since the size and number of HCC cases was not associated with the mean age of HCV-associated HCC patients, it is unlikely that the delay in diagnosis of HCC accounted for aging of HCV-associated HCC cases. Indeed, it is possible that other factors contributed to the steady increase in the mean age of patients with HCV-associated HCC.
Japan with overall HCV prevalence rates similar to that of the United States (approximately 1-2%) but with higher incidence rates of hepatocellular carcinoma (8-10 times lower in the United States) is thought to have had earlier onset and peaks of the HCV epidemic than the United States (5, 8, 9) . A recent study examined the constant evolutionary rate of HCV over time ('the molecular clock') in retrospectively collected serum samples of HCV carriers in Japan and the United States (18) . The study concluded that HCV first appeared in Japan around 1882 and in the United States around 1910, whereas widespread dissemination occurred from 1940s to 1960s in Japan and from 1960s to 1980s in the United States. Risk factors for transmitting HCV were rampant during this period (e.g, injection drug use, needle sharing, and transfusion of unscreened blood and blood products) (19) . It is speculated that these modes of transmission are responsible for differences in the age-specific prevalence of HCV infection in the general population. In the United States, the incidence of HCC continues to increase with the fastest rate among 40-to 50-year-old persons who have the highest rate of HCV infection (20,21). Thus, it is likely that the increasing mean age of patients with HCV-associated HCC in our study was associated with a shift toward an older-age group who had the highest rate of HCV infection.
It is known that 2-4 decades of chronic HCV infection is required to develop cirrhosis and subsequent HCC (22) (23) (24) (25) . The number of HCC cases has increased in Japan, because individuals infected with HCV during the past have grown old and have reached the cancer-bearing age. The prevalence of HCV infection in young Japanese persons is low and the incidence of HCVAb is very low because of preventative actions against HCV infection such as the screening of blood products for HCV and the use of sterile medical equipment (26) . Additionally, we showed that the number of patients with HCV-associated HCC cases reached a plateau together with an increase in the mean age, although the present study was a single-center, hospital-based study. These findings indicate that a decrease in the prevalence of HCC in Japan, a country that is far advanced with regard to HCV-associated HCC, is expected in the near future. We believe that long-term experience in Japan helps to plan strategies against HCVassociated HCC and to cope with its long-term sequelae in many other countries worldwide. Table V . Age-specific prevalence of HCV infection in Nagasaki prefecture, Japan.
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